Skip to main content
. 2022 Sep 9;7(11):2410–2420. doi: 10.1016/j.ekir.2022.08.028

Table 2.

Identifying and comparing barriers to LDKT by LDKT performancea.

Theme % of respondents who agreed/strongly agreed Univariate analysis
 Multivariate analysisb
Ref: high-performing provinces Ref: high-performing provinces
Theme 1: Communication
  • •

    There is good communication between the transplant center and referring centersc

 36.8 0.991.532.38 0.991.733.01
  • •

    The donor evaluation team and recipient evaluation team do not communicate well with each otherc

 26.6 0.300.571.08 0.260.511.01
Theme 2: Referral process
  • •

    I am aware of how to refer living donors to transplant centers

 66.9 0.631.011.60 0.460.791.35
  • •

    The referral and evaluation processes for LDKT is very disorganizedc

 26.5 0.651.111.90 0.611.091.92
Theme 3: Role perception and multidisciplinary involvement
  • •

    Discussions about living donation is a part of my current role

 59.2 0.630.981.53 0.430.721.19
  • •

    The transplant team is best suited to discuss LDKT

 52.7 1.342.113.31d 1.572.554.15d
  • •

    We engage the entire multidisciplinary team in promoting LDKTc

 46.9 0.450.731.19 0.350.611.06
  • •

    I initiate discussions about LDKT with my patient

 51.8 0.410.630.98d 0.160.290.52d
Theme 4: HP’s education, training and comfort
  • •

    LDKT was a part of my training

 43.9 0.600.931.44 0.430.711.19
  • •

    I feel comfortable counseling patients with kidney failure on LDKT

 56.9 0.590.921.43 0.390.661.12
  • •

    I feel comfortable discussing kidney donation with a suitable donor

 47.3 0.931.442.24 0.831.342.18
  • •

    I am aware of the major risks of living donation to the donor

 54.7 0.971.522.36 0.811.372.30
Theme 5: HPs perception on LDKT
  • •

    LDKT is the gold standard of care for patients with kidney failure

 83.0 0.721.322.41 0.571.102.15
  • •

    I know of healthcare providers who feel negatively toward LDKTc

 9.4 0.410.922.06 0.591.403.35
Theme 6: Patient-level barriers as defined by HP
  • •

    LDKT should only be discussed with those who are likely to move forward with it

 13.3 0.621.172.21 0.941.923.93
  • •

    There are patient-level factors that prevent discussions related to LDKTc

 44.8 0.631.021.66 0.520.881.49
Theme 7: Resources and infrastructure
  • •

    My province actively promotes LDKTc

 60.9 0.180.290.48d 0.160.270.47d
  • •

    The current system does not facilitate the evaluation of donorsc

 28.8 0.871.482.5 0.811.412.47
  • •

    There are specific people hired to help patients with LDKTc

 44.2 0.911.492.46 0.751.282.18
  • •

    If I had more resources, I would discuss LDKT more with my patients

 48.7 0.991.532.38 1.312.133.47d

HP, health professionals; LDKT, living donor kidney transplantation.

Participants were asked to rate statements on a Likert scale and percentage who agreed or strongly agreed are reported. We then conducted a logistic regression of the level of agreement with these statement (agreement vs. disagreement/neutral) by LDKT performance in a univariate and a multivariate framework.

a

High-performing provinces were those with living donor rates consistently above the national average of 15 living donors per million population (British Columbia, Ontario, Alberta, Manitoba, and North-West Territories) whereas low-performing provinces were those whose rates were consistently below (Québec, Nova Scotia, New Brunswick, Saskatchewan, Newfoundland and Labrador, and Prince Edward Island).

b

Adjusted for the following respondent characteristics: gender they identified with, their role in the multidisciplinary team, self reported race and years of experience.

c

The option do not know/not applicable was possible.

d

Significant findings.